Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1123542/full |
_version_ | 1797955864759369728 |
---|---|
author | Geeta S. Bhagwat Rajani B. Athawale Rajeev P. Gude Shadab Md Nabil A. Alhakamy Usama A. Fahmy Prashant Kesharwani |
author_facet | Geeta S. Bhagwat Rajani B. Athawale Rajeev P. Gude Shadab Md Nabil A. Alhakamy Usama A. Fahmy Prashant Kesharwani |
author_sort | Geeta S. Bhagwat |
collection | DOAJ |
first_indexed | 2024-04-10T23:39:50Z |
format | Article |
id | doaj.art-dffc91008a7a4b85aa19bf9543a2a1b0 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-04-10T23:39:50Z |
publishDate | 2023-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-dffc91008a7a4b85aa19bf9543a2a1b02023-01-11T10:26:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-01-011310.3389/fphar.2022.11235421123542Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapyGeeta S. Bhagwat0Rajani B. Athawale1Rajeev P. Gude2Shadab Md3Nabil A. Alhakamy4Usama A. Fahmy5Prashant Kesharwani6H. K. College of Pharmacy, Mumbai, IndiaPrin. K. M. Kundanani College of Pharmacy, Mumbai, IndiaAdvanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, IndiaDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, Indiahttps://www.frontiersin.org/articles/10.3389/fphar.2022.1123542/fullbreast cancercancersolid lipid nanoparticlestamoxifentargeted drug delivery |
spellingShingle | Geeta S. Bhagwat Rajani B. Athawale Rajeev P. Gude Shadab Md Nabil A. Alhakamy Usama A. Fahmy Prashant Kesharwani Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy Frontiers in Pharmacology breast cancer cancer solid lipid nanoparticles tamoxifen targeted drug delivery |
title | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
title_full | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
title_fullStr | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
title_full_unstemmed | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
title_short | Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
title_sort | corrigendum formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy |
topic | breast cancer cancer solid lipid nanoparticles tamoxifen targeted drug delivery |
url | https://www.frontiersin.org/articles/10.3389/fphar.2022.1123542/full |
work_keys_str_mv | AT geetasbhagwat corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT rajanibathawale corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT rajeevpgude corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT shadabmd corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT nabilaalhakamy corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT usamaafahmy corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy AT prashantkesharwani corrigendumformulationanddevelopmentoftransferrintargetedsolidlipidnanoparticlesforbreastcancertherapy |